Abbrea Capital, LLC Zoetis Inc. Transaction History

Abbrea Capital, LLC

$755 Million
Q2 2024

A detailed history of Abbrea Capital, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Abbrea Capital, LLC holds 1,396 shares of ZTS stock, worth $246,282. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,396

Previous 2,065 32.4%

Holding current value

$246,282

Previous $349,000 30.66%

% of portfolio

0.03%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$145.54 - $178.83 $97,366 - $119,637	-669 Reduced 32.4%	1,396 $242,000
Q4 2023 Feb 02, 2024	BUY	$151.44 - $200.09 $15,144 - $20,009	100 Added 5.09%	2,065 $408,000
Q3 2023 Oct 31, 2023	BUY	$167.14 - $192.77 $39,946 - $46,072	239 Added 13.85%	1,965 $342,000
Q2 2023 Aug 01, 2023	BUY	$160.94 - $186.23 $277,782 - $321,432	1,726 New	1,726 $297,000
Q4 2022 Feb 08, 2023	SELL	$131.14 - $157.47 $16,392 - $19,683	-125 Reduced 8.19%	1,401 $205,000
Q3 2022 Nov 03, 2022	SELL	$148.29 - $182.55 $66,433 - $81,782	-448 Reduced 22.7%	1,526 $226,000
Q2 2022 Aug 02, 2022	BUY	$155.97 - $200.09 $14,037 - $18,008	90 Added 4.78%	1,974 $339,000
Q4 2021 Feb 04, 2022	SELL	$193.69 - $247.03 $21,886 - $27,914	-113 Reduced 5.66%	1,884 $460,000
Q3 2021 Nov 04, 2021	BUY	$189.29 - $209.69 $3,028 - $3,355	16 Added 0.81%	1,997 $388,000
Q2 2021 Aug 04, 2021	BUY	$155.9 - $187.99 $27,282 - $32,898	175 Added 9.69%	1,981 $369,000
Q1 2021 May 13, 2021	SELL	$144.0 - $169.39 $105,840 - $124,501	-735 Reduced 28.93%	1,806 $284,000
Q4 2020 Jan 21, 2021	BUY	$157.07 - $174.35 $200,264 - $222,296	1,275 Added 100.71%	2,541 $421,000
Q3 2020 Oct 20, 2020	SELL	$137.1 - $165.37 $210,585 - $254,008	-1,536 Reduced 54.82%	1,266 $209,000
Q2 2020 Aug 11, 2020	BUY	$111.92 - $142.53 $15,109 - $19,241	135 Added 5.06%	2,802 $384,000
Q1 2020 Apr 29, 2020	SELL	$92.66 - $144.94 $11,211 - $17,537	-121 Reduced 4.34%	2,667 $314,000
Q4 2019 Feb 11, 2020	BUY	$116.25 - $133.25 $22,668 - $25,983	195 Added 7.52%	2,788 $369,000
Q3 2019 Nov 07, 2019	SELL	$112.57 - $128.43 $101,313 - $115,587	-900 Reduced 25.77%	2,593 $323,000
Q2 2019 Jul 31, 2019	SELL	$97.98 - $114.28 $3,625 - $4,228	-37 Reduced 1.05%	3,493 $396,000
Q1 2019 May 08, 2019	BUY	$81.56 - $100.67 $8,156 - $10,067	100 Added 2.92%	3,530 $355,000
Q3 2018 Nov 09, 2018	BUY	$83.5 - $93.23 $8,099 - $9,043	97 Added 2.91%	3,430 $314,000
Q2 2018 Aug 08, 2018	BUY	$79.9 - $89.2 $4,794 - $5,352	60 Added 1.83%	3,333 $284,000
Q1 2018 May 10, 2018	BUY	$71.51 - $84.69 $234,052 - $277,190	3,273 New	3,273 $273,000

Others Institutions Holding ZTS

# of Institutions

1,956

Shares Held

412M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.6B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbrea Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abbrea Capital, LLC with notifications on news.

Account

Abbrea Capital, LLC Zoetis Inc. Transaction History